Compare Enveric Biosciences Inc (ENVB) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs VanEck Junior Gold Miners — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while VanEck Junior Gold Miners trades at $92.96. The key difference: VanEck Junior Gold Miners is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | GDXJ | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $17.40 | $156.19 |
52-Week Low | $1.28 | $64.22 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
GDXJ, the VanEck Junior Gold Miners ETF, trades at $93.33, down 5.12% in the last 24 hours amid a bearish technical signal. Technical indicators show moving averages are bearish, while oscillators are neutral. Recent news highlights underperformance versus peers and questions about its small-cap focus. Key support lies at $91, with resistance at $98.
The outlook for GDXJ is cautious due to weak technicals and negative sentiment. Risks include Federal Reserve rate hike expectations and competition from other gold ETFs. Analyst consensus is bearish, with limited fundamental data available. Investors should weigh macroeconomic factors affecting gold miners before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
